NEW YORK CITY -- The newer Navitor looked increasingly viable as a transcatheter aortic valve replacement (TAVR) system, based on its largest report of commercial use to date. In the U.S., the Navitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback